Profil bibliographique

Gareth Burns

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

13Publications signalées

210Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Hepatitis B Virus StudiesHepatitis C virus researchHepatitis Viruses Studies and EpidemiologyLiver Disease Diagnosis and TreatmentHIV/AIDS drug development and treatment

Publications récentes

Accès ouvert 2025 article

Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B

Simon J. Hume, Kumar Visvanathan, Keding Cheng, K. Jackson et autres

2 citationsThe Journal of Infectious Diseases

Accès ouvert 2025 article

Long‐Term Follow‐Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg Loss

Simon J. Hume, Samuel Hall, Gareth Burns, Sara Vogrin et autres

2 citationsAlimentary Pharmacology & Therapeutics

Accès ouvert 2024 article

High end‐of‐treatment hepatitis B core‐related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy

Simon J. Hume, Danny K. Wong, Man‐Fung Yuen, K. Jackson et autres

13 citationsLiver International

Accès ouvert 2023 article

Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants

Alexander Thompson, Kathy Merlock Jackson, Sara Bonanzinga, Sam A. Hall et autres

20 citationsHepatology Communications

2022 article

Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways

Samuel Hall, Gareth Burns, Benjamin J Mooney, Rosemary Millen et autres

4 citationsThe Journal of Infectious Diseases

2022 article

Serum HBV RNA levels are associated with risk of hepatitis flare after stopping NA therapy in HBeAg-negative patients

Kathy Merlock Jackson, Kumar Visvanathan, S. Hall, Gareth Burns et autres

1 citationJournal of Hepatology

2022 article

Stopping nucleot(s)ide analogues in non‐cirrhotic HBeAg ‐negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels

Samuel Hall, Gareth Burns, Despina Anagnostou, Sara Vogrin et autres

37 citationsAlimentary Pharmacology & Therapeutics

2021 review

Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis

Samuel Hall, Sara Vogrin, Olivia Wawryk, Gareth Burns et autres

68 citationsGut

2021 article

Test and vaccinate or remove: Methodology and preliminary results from a badger intervention research project

F. D. Menzies, Carl McCormick, Maria O’Hagan, Shane F. Collins et autres

37 citationsVeterinary Record

Accès ouvert 2020 article

A prospective study of nucleot(s)ide analogue discontinuation in non-cirrhotic HBeAg-negative chronic hepatitis B patients: interim analysis at week 48 demonstrates profound reductions of HBsAg associated with ALT flare

Samuel Hall, Gareth Burns, Miriam Levy, John Lubel et autres

3 citationsJournal of Hepatology

2020 article

A prospective study of nucleot(s)ide analog discontinuation in non-cirrhotic patients with HBeAg-negative chronic hepatitis B: Interim analysis identifies different viral kinetics after stopping tenofovir versus entecavir

Samuel Hall, Gareth Burns, Dimitra Anagnostou, Sara Vogrin et autres

0 citationsJournal of Gastroenterology and Hepatology

2017 article

Discontinuation of nucleoside analogue therapy in e-antigen-negative chronic hepatitis B: A meta-analysis

Gareth Burns, Sara Vogrin, Anna Sutherland, Vijaya Sundararajan et autres

0 citationsJournal of Gastroenterology and Hepatology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.